Similar articles

• Clinical studies: treatment of tuberculosis with isonicotinic acid hydrazine and its derivatives.

  ORNSTEIN GG, ROBITZEK EH, SELIKOFF IJ. ORNSTEIN GG, et al. Trans Annu Meet Natl Tuberc Assoc. 1952;48:433-8. Trans Annu Meet Natl Tuberc Assoc. 1952. PMID: 13038912 No abstract available.
• [Isoniazid in the treatment of tuberculosis; our experience].

  CORACH L, DE PIFFARETTI MM, MOLINA MA. CORACH L, et al. Prensa Med Argent. 1955 Apr 29;42(17):1200-4. Prensa Med Argent. 1955. PMID: 13245674 Spanish. No abstract available.
• The use of intermittent (twice weekly) streptomyclidene isonicotyl hydrazine sulphate in the treatment of pulmonary tuberculosis (without oral INH).

  SHUBIN H, HEIKEN CA, GLASKIN A, PENNES E, CHAKRAVARTY S. SHUBIN H, et al. Tuberculol Thorac Dis. 1954 Dec;14(4):220-4. Tuberculol Thorac Dis. 1954. PMID: 13226427 No abstract available.
• [Clinical experience with dipasic and isoniazid-PAS compounds in therapy of tuberculosis].

  BOHLKE E, SCHOEPS U. BOHLKE E, et al. Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1956;115(2):145-53. Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1956. PMID: 13328754 German. No abstract available.
• Experience with streptomycylidene isonicotinyl hydrazine sulfate in the treatment of mentally sick tuberculous patients.

  ROSENFELD R. ROSENFELD R. Antibiotic Med Clin Ther (New York). 1955 Aug;1(8):446-9. Antibiotic Med Clin Ther (New York). 1955. PMID: 13239099 No abstract available.